Business Description
Heart Test Laboratories Inc
NAICS : 423450
SIC : 5047
ISIN : US42254E1047
Description
Heart Test Laboratories Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.61 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -10.58 | |||||
| Beneish M-Score | -222.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -45 | |||||
| 3-Year EBITDA Growth Rate | 15.2 | |||||
| 3-Year EPS without NRI Growth Rate | 17.3 | |||||
| 3-Year FCF Growth Rate | 17 | |||||
| Future 3-5Y Total Revenue Growth Rate | 784.98 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.92 | |||||
| 9-Day RSI | 46.47 | |||||
| 14-Day RSI | 43.21 | |||||
| 6-1 Month Momentum % | -68.18 | |||||
| 12-1 Month Momentum % | -94.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.2 | |||||
| Quick Ratio | 3.84 | |||||
| Cash Ratio | 3.32 | |||||
| Days Inventory | 34685.43 | |||||
| Days Sales Outstanding | 182.5 | |||||
| Days Payable | 31671.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -103.7 | |||||
| Shareholder Yield % | -344.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.16 | |||||
| Operating Margin % | -33189.47 | |||||
| Net Margin % | -34763.16 | |||||
| FCF Margin % | -32605.26 | |||||
| ROE % | -235.69 | |||||
| ROA % | -115.65 | |||||
| ROIC % | -303.85 | |||||
| ROC (Joel Greenblatt) % | -812.66 | |||||
| ROCE % | -175.23 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 53.08 | |||||
| PB Ratio | 0.32 | |||||
| Price-to-Tangible-Book | 0.44 | |||||
| EV-to-EBIT | 0.29 | |||||
| EV-to-EBITDA | 0.3 | |||||
| EV-to-Forward-EBITDA | -1.08 | |||||
| EV-to-Revenue | -95.68 | |||||
| EV-to-Forward-Revenue | 24.21 | |||||
| EV-to-FCF | 0.29 | |||||
| Price-to-Net-Current-Asset-Value | 0.49 | |||||
| Price-to-Net-Cash | 0.7 | |||||
| Earnings Yield (Greenblatt) % | 344.83 | |||||
| FCF Yield % | -209.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HSCS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Heart Test Laboratories Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.019 | ||
| EPS (TTM) ($) | -34.729 | ||
| Beta | 0 | ||
| Volatility % | 49.79 | ||
| 14-Day RSI | 43.21 | ||
| 14-Day ATR ($) | 0.357807 | ||
| 20-Day SMA ($) | 3.530665 | ||
| 12-1 Month Momentum % | -94.18 | ||
| 52-Week Range ($) | 3.0301 - 85.18 | ||
| Shares Outstanding (Mil) | 0.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Heart Test Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Heart Test Laboratories Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Heart Test Laboratories Inc Frequently Asked Questions
What is Heart Test Laboratories Inc(HSCS)'s stock price today?
The current price of HSCS is $3.72. The 52 week high of HSCS is $85.18 and 52 week low is $3.03.
When is next earnings date of Heart Test Laboratories Inc(HSCS)?
The next earnings date of Heart Test Laboratories Inc(HSCS) is .
Does Heart Test Laboratories Inc(HSCS) pay dividends? If so, how much?
Heart Test Laboratories Inc(HSCS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers